Skip to main content
Fig. 7 | BMC Pulmonary Medicine

Fig. 7

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Fig. 7

Network evidence map of FVC (L) absolute change from baseline. A total of 11 studies reported the FVC (% predicted) absolute change from baseline in patients with IPF treated with 9 drugs:1 of Bosentan, 1 of GLPG1690, 1 of Imatinib, 1 of Macitentan, 1 of N-acetylcysteine, 3 of Nintedanib, 1 of Pamrevlumab, 1 of PRM-151, 1 of Warfarin

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us